{"id":"nordilet","safety":{"commonSideEffects":[{"rate":"null","effect":"Hypoglycemia"},{"rate":"null","effect":"Nausea"},{"rate":"null","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"DPP-4 inhibitors like Nordilet work by blocking the action of DPP-4, an enzyme that breaks down incretin hormones. This leads to increased levels of incretin hormones, which in turn stimulate the release of insulin from the pancreas in a glucose-dependent manner, thereby lowering blood glucose levels.","oneSentence":"Nordilet is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which increases the levels of incretin hormones to enhance glucose-dependent insulin secretion.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:50:37.096Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT03223025","phase":"PHASE3","title":"Comparing Efficacy and Safety of CinnaGen Biosimilar Growth Hormone (CinnaTropin®) Versus Nordilet in Children With Idiopathic Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Cinnagen","startDate":"2016-03-09","conditions":"Idiopathic Growth Hormone Deficiency","enrollment":30},{"nctId":"NCT01778023","phase":"PHASE3","title":"Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2013-01-17","conditions":"Growth Disorder, Idiopathic Short Stature","enrollment":54}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["recombinant human growth hormone (Nordilet®)"],"phase":"phase_3","status":"active","brandName":"Nordilet®","genericName":"Nordilet®","companyName":"Cinnagen","companyId":"cinnagen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Nordilet is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which increases the levels of incretin hormones to enhance glucose-dependent insulin secretion. Used for Type 2 diabetes.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}